| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/2011 | US20110212937 Compounds for the reduction of beta-amyloid production |
| 09/01/2011 | US20110212936 High-valent palladium fluoride complexes and uses thereof |
| 09/01/2011 | US20110212935 Compositions and treatment methods-4 |
| 09/01/2011 | US20110212934 Pharmaceutical preparations for treatments of diseases and disorders of the breast |
| 09/01/2011 | US20110212933 Antiseptic Compositions for the Treatment of Infections |
| 09/01/2011 | US20110212932 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
| 09/01/2011 | US20110212931 Antioxidant |
| 09/01/2011 | US20110212930 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 09/01/2011 | US20110212929 Protein Kinase Inhibitors |
| 09/01/2011 | US20110212928 Methods and compositions for improving cognitive function |
| 09/01/2011 | US20110212927 Carbonate prodrugs and methods of using the same |
| 09/01/2011 | US20110212926 Water-soluble acetaminophen analogs |
| 09/01/2011 | US20110212925 Novel compounds as receptor modulators with therapeutic utility |
| 09/01/2011 | US20110212924 Compositions and methods to treat cardiac diseases |
| 09/01/2011 | US20110212923 Phosphate Derivatives of Substituted Benzoxazoles |
| 09/01/2011 | US20110212922 Processes for the preparation of phosphatide salts |
| 09/01/2011 | US20110212921 Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof |
| 09/01/2011 | US20110212920 N-Substituted Benzene Sulfonamides |
| 09/01/2011 | US20110212919 Protein cross-linking inhibitor |
| 09/01/2011 | US20110212918 Boron-containing small molecules |
| 09/01/2011 | US20110212917 Agent for ameliorating brain hypofunction |
| 09/01/2011 | US20110212916 Method and means for improving bowel health |
| 09/01/2011 | US20110212915 Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
| 09/01/2011 | US20110212914 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
| 09/01/2011 | US20110212913 Therapeutic compositions comprising phenolic acids for treating conditions related to inappropriate platelet aggregation |
| 09/01/2011 | US20110212912 Optimised formulation of tobramycin for aerosolization |
| 09/01/2011 | US20110212911 Transcription factor inhibitors and related compositions, formulations and methods |
| 09/01/2011 | US20110212910 Antioxidant |
| 09/01/2011 | US20110212909 Use of Ginsenoside Compound K in the Preparation of a Medicament for the Prevention and Treatment of Atherosclerosis |
| 09/01/2011 | US20110212908 Topical compositions and the use thereof |
| 09/01/2011 | US20110212907 Hexadecasaccharides with antithrombotic activity, including a covalent bond and an amino chain |
| 09/01/2011 | US20110212906 C-linked glucuronide of n-(4-hydroxybenzyl) retinone, analogs thereof, and methods of using the same to inhibit neoplastic cell growth |
| 09/01/2011 | US20110212905 Crystalline form of 1-(beta-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate |
| 09/01/2011 | US20110212904 Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug |
| 09/01/2011 | US20110212895 Treatment of Cognitive and Learning Impairment |
| 09/01/2011 | US20110212892 Agent for treatment of diabetes |
| 09/01/2011 | US20110212888 Diet and methods for improving learning capacity, mood and behavior in mammals |
| 09/01/2011 | US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 09/01/2011 | US20110212243 Parenteral selenomethionine for production of selenium-rich foods |
| 09/01/2011 | US20110212200 Agent for treating eye diseases |
| 09/01/2011 | US20110212199 Agent for treating eye diseases |
| 09/01/2011 | US20110212196 Therapeutic oil composition containing carvone |
| 09/01/2011 | US20110212194 Composition for Inhibiting Melanogenesis and Use Thereof |
| 09/01/2011 | US20110212192 Ingestibles containing sugar and cinnamon or ginseng |
| 09/01/2011 | US20110212191 Composition for the maintenance of blood sugar levels comprising cinnamon and ginseng |
| 09/01/2011 | US20110212188 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 09/01/2011 | US20110212186 Composition for treating autoimmune disorders |
| 09/01/2011 | US20110212182 Masked taste pharmaceutical granules/granulates |
| 09/01/2011 | US20110212181 Compositions and methods for treating chronic respiratory inflammation |
| 09/01/2011 | US20110212180 Method of producing microcapsules |
| 09/01/2011 | US20110212178 Injectable Hydrogel Filaments For Biomedical Uses |
| 09/01/2011 | US20110212176 Ciclopirox and cytarabine for the treatment of leukemic disorders |
| 09/01/2011 | US20110212175 Combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor |
| 09/01/2011 | US20110212174 Controlled release arginine formulations |
| 09/01/2011 | US20110212173 Controlled Release Treatment of Depression |
| 09/01/2011 | US20110212172 Administration of an adsorbent polymer for treatment of systemic inflammation |
| 09/01/2011 | US20110212171 Taste masked topiramate composition and an orally disintegrating tablet comprising the same |
| 09/01/2011 | US20110212170 Formulation For Retinoid-Containing Soft Gelatin Capsules |
| 09/01/2011 | US20110212169 METHOD FOR PRODUCING POWDER CONTAINING NANOPARTICULATED SPARINGLY SOLUBLE DRUG, POWDER PRODUCED THEREBY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME (As Amended) |
| 09/01/2011 | US20110212167 Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof |
| 09/01/2011 | US20110212166 Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses |
| 09/01/2011 | US20110212165 Pharmaceutical compositions of the isolated d-enantiomer of the quinazolinone derivative halofuginone |
| 09/01/2011 | US20110212161 Treatment skin disorders |
| 09/01/2011 | US20110212157 Dermal delivery |
| 09/01/2011 | US20110212156 Use of a mixture of two or more enteric materials to regulate drug release via membrance or matrix for systemic therapeutics |
| 09/01/2011 | US20110212154 Biodegradable Implantable Drug Delivery Device |
| 09/01/2011 | US20110212150 Process for the treatment of cellulosic molded bones |
| 09/01/2011 | US20110212146 Compositions |
| 09/01/2011 | US20110212142 Curcuminoids and its metabolites for the application in ocular diseases |
| 09/01/2011 | US20110212141 Injectable depot formulation comprising crystals of iloperidone |
| 09/01/2011 | US20110212140 Pressure-sensitive adhesive composition applicable to nail and adhesive agent for nail |
| 09/01/2011 | US20110212138 Sustained release formulations using non-aqueous carriers |
| 09/01/2011 | US20110212137 Inhalable pharmaceutical composition |
| 09/01/2011 | US20110212135 Oligodeoxynucleotide and its use to induce an immune response |
| 09/01/2011 | US20110212115 Melk epitope peptides and vaccines containing the same |
| 09/01/2011 | US20110212110 Compositions and Methods for Detecting TLR3 |
| 09/01/2011 | US20110212108 Neuregulin/erbb signaling and integrin |
| 09/01/2011 | US20110212107 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 09/01/2011 | US20110212106 Hiv-1 neutralizing antibodies and uses thereof |
| 09/01/2011 | US20110212103 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 09/01/2011 | US20110212102 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | US20110212100 Methods for modulating development and expansion of il-17 expressing cells |
| 09/01/2011 | US20110212098 Novel Melanoma Antigen Peptide and Uses Thereof |
| 09/01/2011 | US20110212097 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases |
| 09/01/2011 | US20110212090 Combinatorial Analysis and Repair |
| 09/01/2011 | US20110212089 Targeting pax2 for the treatment of breast cancer |
| 09/01/2011 | US20110212083 Role of soluble upar in the pathogenesis of proteinuric kidney disease |
| 09/01/2011 | US20110212081 Krüppel-like factors and fat regulation |
| 09/01/2011 | US20110212080 Urea derivatives as antibacterial agents |
| 09/01/2011 | US20110212079 Adaptive biochemical signatures |
| 09/01/2011 | US20110212078 Synthesis and use of heterocyclic antibacterial agents |
| 09/01/2011 | US20110212077 Bi-aryl meta-pyrimidine inhibitors of kinases |
| 09/01/2011 | US20110212076 Viral Therapeutic |
| 09/01/2011 | US20110212072 Inhibitors of Fatty Acid Oxidation for Prophylaxis and Treatment of Diseases Related to Mitochondrial Dysfunction |
| 09/01/2011 | US20110212058 Targeted modulation of gene expression |
| 09/01/2011 | US20110212056 Combination therapy for the treatment of liver diseases |
| 09/01/2011 | US20110212054 Thrombopoietin mimetics |
| 09/01/2011 | US20110212053 Phosphatidylinositol 3 kinase inhibitors |
| 09/01/2011 | US20110212050 Side-chain crystallizable polymers for medical applications |
| 09/01/2011 | US20110212049 Polymer compositions of dihydroxyacetone and uses thereof |